A QuICR test to diagnose Parkinson's disease

Albert A. Davis

doi:10.1126/scitranslmed.abg1761

A QuICR test to diagnose Parkinson's disease

Research output: Contribution to journal › Review article › peer-review

Abstract

Refined conditions permit rapid detection of proteopathic a-synuclein seeds in cerebrospinalfluid from patients with Parkinson's disease.

Original language	English
Article number	eabg1761
Journal	Science translational medicine
Volume	13
Issue number	576
DOIs	https://doi.org/10.1126/scitranslmed.abg1761
State	Published - Jan 13 2021

Access to Document

10.1126/scitranslmed.abg1761

Cite this

@article{75db1e06999a4cc088a9e9ea21436c10,

title = "A QuICR test to diagnose Parkinson's disease",

abstract = "Refined conditions permit rapid detection of proteopathic a-synuclein seeds in cerebrospinalfluid from patients with Parkinson's disease.",

author = "Davis, {Albert A.}",

year = "2021",

month = jan,

day = "13",

doi = "10.1126/scitranslmed.abg1761",

language = "English",

volume = "13",

journal = "Science Translational Medicine",

issn = "1946-6234",

number = "576",

}

TY - JOUR

T1 - A QuICR test to diagnose Parkinson's disease

AU - Davis, Albert A.

PY - 2021/1/13

Y1 - 2021/1/13

N2 - Refined conditions permit rapid detection of proteopathic a-synuclein seeds in cerebrospinalfluid from patients with Parkinson's disease.

AB - Refined conditions permit rapid detection of proteopathic a-synuclein seeds in cerebrospinalfluid from patients with Parkinson's disease.

UR - http://www.scopus.com/inward/record.url?scp=85101380545&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.abg1761

DO - 10.1126/scitranslmed.abg1761

M3 - Review article

AN - SCOPUS:85101380545

SN - 1946-6234

VL - 13

JO - Science Translational Medicine

JF - Science Translational Medicine

IS - 576

M1 - eabg1761

ER -

A QuICR test to diagnose Parkinson's disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this